MY ACCOUNT | NEWSLETTER |

Veterinary electrosurgery to pass $100M


The global market for veterinary electrosurgery was expected to grow to $112 million by 2027, according to a market report by MarketsandMarkets. The sector was valued at $77 million in 2022. Projected growth across the market would amount to a CAGR of 7.7%. 

Growth is pinned on the higher degree of spending on animal health and increased utilization of veterinary care all due to the increased rate of pet adoption and ownership. This growth has filtered out to an increase in the demand for veterinary electrosurgical instruments.

When viewed by product segments, the market was divided into bipolar electrosurgery instruments, monopolar electrosurgery instruments, and consumables along with accessories. Within the segments, bipolar electrosurgery instruments were found to make up the greatest share of the 2021 market. The result was based in part on the low number of uses of monopolar electrosurgery devices as a treatment for damaged tissue. 

Based on a segment for type of animal, the market was led by small animals in 2021 compared to large animals. The difference was based on the large number of companion animals and desire to spend on their health maintenance. In that same concept, the sector of end users was led by veterinary clinics as they typically manage the bulk of animal companion veterinary visits. 

By region, North America led the market in 2021 as the demand for companion animal care was high in this area, and the amount of spending in companion animal health was also high, including enrolment in pet insurance coverage. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Legacy fuels UWVC leadership in comprehensive cancer care

Like0
Dislike0

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top